Skip to content

Health Catalyst HCAT Shares, Outstanding

Other financials

Income statement

See full
Revenue$70.8M-10.9%
Gross profit$35.5M-2.1%
Operating income-$106.5M-428%
Net income-$111.0M-368%
EPS (diluted)-$1.53-337%

Balance sheet

See full
Cash & equivalents$59.9M-82.5%
Total debt$170.6M-57.6%
Total equity$138.1M-63.3%
Total assets$412.2M-53.8%

Cash flow

See full
Operating cash flow$18.5M+6,511%
CapEx$338.0K-49.6%
Free cash flow$18.2M+4,760%

Valuation

See full
Market cap$147.05M-43.6%
Enterprise value$257.76M-32.7%
P/S0.5×-0.3×

Profitability

See full
Gross margin49.9%+4.7pp
Operating margin-81.7%-127pp
Net margin-87.7%-138pp
FCF margin-0.8%-0.4pp

Returns & leverage

See full
Return on equity-103%-135pp
Debt / equity1.2×+0.2×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Health Catalyst in its filing.

Tagged under the XBRL concept us-gaap:SharesOutstanding.

The official record: Health Catalyst’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Health Catalyst's shares, outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Health Catalyst's shares, outstanding?
Health Catalyst (HCAT) reported shares, outstanding of $73.85M in Q1 2026.
How has Health Catalyst's shares, outstanding changed year-over-year?
Health Catalyst's shares, outstanding increased by 6.1% year-over-year, from $69.59M to $73.85M.
What is the long-term trend for Health Catalyst's shares, outstanding?
Over 5 years (2020 to 2025), Health Catalyst's shares, outstanding has grown at a 10.5% compound annual growth rate (CAGR), from $43.71M to $72.13M.